Skip to main content
BGLC logo

BGLC · BioNexus Gene Lab Corp · Executive Compensation

Track BGLC — free
$1.21 -0.02 (-1.86%) At close · Oct 20
Market Cap
$3.53M
Shares
2.93M
Volume · Oct 20 1043 Avg daily vol (3M) 11.4K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Chong Set Fui (Angeline) Appointed 2025-06-23
Su-Leng Tan Lee Appointed 2024-11-08
Jook Yuen Low Appointed 2024-11-08
Koon Wai Wong Resigned 2024-10-15
Koon Wai Wong Resigned 2024-10-15
Wei Foong Lim Resigned 2024-10-15
Su-Leng Tan Lee Appointed 2024-04-01
Chee Keong Yap Appointed 2024-04-01
Su-Leng Tan Lee Appointed 2024-04-01
Wei Li Leong Resigned 2023-11-03
Chi Yuen Leong Appointed 2023-10-16
Chi Yuen Leong Appointed 2023-10-16
Sook Keng Yeoh Resigned 2023-10-11
Sook Keng Yeoh Resigned 2023-10-11
Lee Su-Leng Tan Appointed 2023-09-07
Liong Tai Tan Resigned 2023-09-07
Liong Tai Tan Resigned 2023-09-07
Sook Keng Yeoh Appointed 2022-08-15
Yeat Min Fong Appointed 2022-08-15

Leadership

Key facts CIK 1737523 CUSIP 090628306 Visit website Investor relations